Randomized Phase III Trial Comparing Single-Agent Paclitaxel Poliglumex (CT-2103, PPX) with Single-Agent Gemcitabine or Vinorelbine for the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer
Author(s) -
V.L. Ganul,
Jack W. Singer,
F. B. Oldham,
Igor Bondarenko,
Yevhen Hotko,
Alexander Y. Popovich,
Ippolit Y. Kostinsky,
Antoaneta Tomova,
Amy J. Eisenfeld,
Alan B. Sandler,
B. Bandstra,
Mark A. Socinski,
Larissa Sandalic,
Mary O’Brien,
Borys T. Bilynsky ̆ı
Publication year - 2021
Publication title -
unc libraries
Language(s) - English
DOI - 10.17615/ygtf-rq83
Subject(s) - vinorelbine , gemcitabine , medicine , chemotherapy , paclitaxel , oncology , cisplatin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom